MyAverix Finance
JK · Healthcare
Indofarma Tbk (INAF)
Drug Manufacturers - Specialty & Generic
Indofarma Tbk (INAF) is listed on JK in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for INAF
Indofarma Tbk (INAF) — FAQ
What is INAF's P/E ratio?
The price-to-earnings (P/E) ratio for Indofarma Tbk (INAF) is 18.00 (data as of 2026-05-23).
Does Indofarma Tbk pay a dividend?
Dividend yield is not available in the current snapshot for Indofarma Tbk (INAF). Check the MyAverix Finance app for the latest dividend data.
What sector is Indofarma Tbk in?
Indofarma Tbk (INAF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is INAF listed on?
INAF is listed on JK.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.